Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya-Reference-Cited by-同舟云学术

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya

Published:2017-06-07 Issue:1 Volume:15 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Flasche Stefan^ORCID,Ojal John,Le Polain de Waroux Olivier,Otiende Mark,O’Brien Katherine L.,Kiti Moses,Nokes D. James,Edmunds W John,Scott J. Anthony G.

Funder

GAVI Alliance

Wellcome Trust (GB)

Wellcome Trust

GAVI Alliance (CH)

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-017-0882-9.pdf

Reference42 articles.

1. International Vaccine Access Center - Johns Hokins Bloomberg School of Public Health. PCV introduction status [Internet]. 2015. http://www.jhsph.edu/research/centers-and-institutes/ivac/resources/maps.html . Accessed 5 Sept 2016.

2. UNICEF. Supply Division. Pneumococcal conjugate vaccine: supply & demand update. Copenhagen: UNICEF Supply Division; 2014.

3. World Health Organization. Pneumococcal vaccines — WHO position paper. Wkly Epidemiol Rec. 2012;14:129–44.

4. Scott JAG, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol. 2012;41:650–7.

5. Kinyanjui TM. Modelling the transmission dynamics of RSV and the impact of routine vaccination. Coventry: University of Warwick; 2013.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term impact of 10-valent pneumococcal conjugate vaccine in Kenya: Nasopharyngeal carriage among children in a rural and an urban site six years after introduction;Vaccine;2024-11

2. Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine;The Lancet Global Health;2024-09

3. Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13;Journal of Medical Economics;2024-04-19

4. Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021;Emerging Infectious Diseases;2024-03

5. Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy;Vaccines;2024-01-03